MedTrace Logo

Perceived Barriers to Patient Adherence After Pediatric Solid Organ Transplantation

NCT01370746 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 502

Last updated 2017-06-05

No results posted yet for this study

Summary

In this study, doctors will observe how and when pediatric patients who have received a solid organ transplant take their prescribed medication, and determining if there are reasons that keep these patients from taking all of their medicine.

Conditions

  • Organ Transplantation

Sponsors & Collaborators

  • Clinical Trials in Organ Transplantation in Children

    collaborator OTHER

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Stuart Sweet, MD, PhD · Washington University School of Medicine

  • Lara Danziger-Isakov, MD, MPH · Children's Hospital Medical Center, Cincinnati

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01370746 on ClinicalTrials.gov